EP2197448A4 - Dosierplan - Google Patents

Dosierplan

Info

Publication number
EP2197448A4
EP2197448A4 EP08830097A EP08830097A EP2197448A4 EP 2197448 A4 EP2197448 A4 EP 2197448A4 EP 08830097 A EP08830097 A EP 08830097A EP 08830097 A EP08830097 A EP 08830097A EP 2197448 A4 EP2197448 A4 EP 2197448A4
Authority
EP
European Patent Office
Prior art keywords
dosing regimen
regimen
dosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08830097A
Other languages
English (en)
French (fr)
Other versions
EP2197448A1 (de
Inventor
Gary Liversidge
Scott Jenkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharma International Ltd
Original Assignee
Elan Pharma International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharma International Ltd filed Critical Elan Pharma International Ltd
Publication of EP2197448A1 publication Critical patent/EP2197448A1/de
Publication of EP2197448A4 publication Critical patent/EP2197448A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
EP08830097A 2007-09-12 2008-09-12 Dosierplan Withdrawn EP2197448A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97188207P 2007-09-12 2007-09-12
PCT/US2008/076189 WO2009036287A1 (en) 2007-09-12 2008-09-12 Dosing regimen

Publications (2)

Publication Number Publication Date
EP2197448A1 EP2197448A1 (de) 2010-06-23
EP2197448A4 true EP2197448A4 (de) 2010-11-17

Family

ID=40452511

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08830097A Withdrawn EP2197448A4 (de) 2007-09-12 2008-09-12 Dosierplan

Country Status (4)

Country Link
EP (1) EP2197448A4 (de)
JP (1) JP2010539184A (de)
CA (1) CA2697189A1 (de)
WO (1) WO2009036287A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0979635A2 (de) 1998-08-12 2000-02-16 Origin Medsystems, Inc. Gewebedissektor
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (de) 1999-10-29 2011-03-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
KR101167465B1 (ko) 2000-10-30 2012-07-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US6558313B1 (en) 2000-11-17 2003-05-06 Embro Corporation Vein harvesting system and method
US9149472B2 (en) 2004-08-31 2015-10-06 Jack William Schultz Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
US9770230B2 (en) 2006-06-01 2017-09-26 Maquet Cardiovascular Llc Endoscopic vessel harvesting system components
US10322120B2 (en) 2012-07-31 2019-06-18 Persion Pharmaceuticals Llc Treating pain in patients with hepatic impairment
US20140161879A1 (en) * 2012-07-31 2014-06-12 Zogenix, Inc. Treating pain in patients with hepatic impairment
AR094117A1 (es) * 2012-12-20 2015-07-08 Sanofi Aventis Deutschland Conjunto de envasado para dispositivos de administracion de farmacos
CA2928899C (en) * 2013-11-04 2021-02-16 Jack William SCHULTZ Treatment of cognitive, emotional and mental ailments and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US7674776B2 (en) * 1999-06-14 2010-03-09 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
BR0206062A (pt) * 2001-09-28 2004-01-13 Mcneil Ppc Inc Formas de dosagem tendo um núcleo interno e invólucro externo
GB0201367D0 (en) * 2002-01-22 2002-03-13 Ml Lab Plc Composition
JP5563731B2 (ja) * 2003-09-26 2014-07-30 アルザ・コーポレーシヨン オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
US7188738B2 (en) * 2004-03-18 2007-03-13 Customer Advantage Llc Medication minder
US8715727B2 (en) * 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Famvir 500 mg Filmtabletten", 29 January 2001 (2001-01-29), XP002601168, Retrieved from the Internet <URL:http://www.pharmazie.com/graphic/A/09/1-21509.pdf> [retrieved on 20100916] *
ANONYMOUS: "Provigil", 11 September 2007 (2007-09-11), XP002601171, Retrieved from the Internet <URL:http://www.rxlist.com/provigil-drug.htm> [retrieved on 20100917] *
ANONYMOUS: "Rote Liste 2004", 2004, ECV EDITIO CANTOR VERLAG, Aulendorf, pages: 05-027, XP002601170 *
AVGERINOS A. ET AL.: "Pharmacokinetics of Nifedipine Derived from New Retard Tablet Formulation", EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, vol. 15, no. 4, 1990, pages 273 - 278, XP009138838 *
LEE DANIEL K C ET AL: "Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine mono phosphate challenge in persistent allergic rhinitis", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol. 57, no. 6, June 2004 (2004-06-01), pages 714 - 719, XP002601169, ISSN: 0306-5251 *
See also references of WO2009036287A1 *

Also Published As

Publication number Publication date
CA2697189A1 (en) 2009-03-19
WO2009036287A1 (en) 2009-03-19
EP2197448A1 (de) 2010-06-23
JP2010539184A (ja) 2010-12-16

Similar Documents

Publication Publication Date Title
GB2451284B (en) Flowmeter
IL234296B (en) dosage regimen
AU318966S (en) Packaging
AU320395S (en) Packaging
AU315662S (en) Package
EP2197448A4 (de) Dosierplan
GB0710229D0 (en) Detergent dosing device
ZA201008885B (en) Telaprevir dosing regimen
PL2291107T3 (pl) Urządzenie dozujące
EP2249132A4 (de) Durchflussmesser
GB0721439D0 (en) Packaging
PL2342060T3 (pl) Urządzenie dozujące
HK1159005A1 (en) Dosing device
GB0710230D0 (en) Detergent dosing device
GB0715606D0 (en) Packaging
GB2454144B (en) Dosing device
PL1970496T3 (pl) Układ dozujący
GB0720002D0 (en) Packaging
GB0717987D0 (en) Packaging
AU316596S (en) Packaging
GB0704321D0 (en) Packaging
GB2446586B (en) Packaging
PL383266A1 (pl) Urządzenie dozujące
PL384667A1 (pl) Dozownik
GB0804860D0 (en) Dosing fill

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100329

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20101015

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20120813

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130103